Showing results (151-160 of 158) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
The Annals of Pharmacotherapy|June 15, 2014
Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From CancerHiroaki Ikesue, Toshikazu Tsuji, Koujiro Hata, et al.Therapeutic Drug Monitoring|August 9, 2022
Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19Florian Lemaitre, Klemens Budde, Teun Van Gelder, et al.Therapeutic Drug Monitoring|March 17, 2016
Therapeutic Drug Monitoring of Everolimus: A Consensus ReportMaria Shipkova, Dennis A Hesselink, David W Holt, et al.Journal of the American Society of Nephrology : JASN|October 31, 2009
SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammationTakafumi Toyohara, Takehiro Suzuki, Ryo Morimoto, et al.Journal of the American Society of Nephrology : JASN|May 17, 2014
Conformational change in transfer RNA is an early indicator of acute cellular damageEikan Mishima, Chisako Inoue, Daisuke Saigusa, et al.Therapeutic Drug Monitoring|September 27, 2024
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical ToxicologySatohiro Masuda, Florian Lemaitre, Markus J Barten, et al.Therapeutic Drug Monitoring|March 12, 2021
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStein Bergan, Mercè Brunet, Dennis A Hesselink, et al.Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.Pageof 16